KalVista Pharmaceuticals, Inc. (KALV) Stock News & Chart

(KALV)

KalVista Pharmaceuticals, Inc.

Stock chart and latest news for KalVista Pharmaceuticals, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

KalVista Pharmaceuticals, Inc. News

PRO

Stock Titan

KALV SEC Filings - Kalvista Pharm 10-K, 10-Q, 8-K Forms

Apr 14, 2026 Sahm

How Investors May Respond To KalVista Pharmaceuticals (KALV) Early KONFIDENT-KID Completion And Positive EKTERLY Data

Apr 14, 2026 Yahoo Finance

TD Cowen Bullish on KalVista Pharmaceuticals, Inc. (KALV) Ahead of Q4 Results

Feb 2, 2026 Business Wire

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 2, 2026 Seeking Alpha

KalVista Pharmaceuticals: Ekterly's Launch Momentum Keeps The Bull Case Alive (KALV)

Apr 7, 2026 The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), KalVista Pharmaceuticals (KALV) and Ionis Pharmaceuticals (IONS)

Mar 27, 2026 Yahoo Finance

Wall Street Analysts Believe KalVista Pharmaceuticals (KALV) Could Rally 116.4%: Here's is How to Trade

Feb 2, 2026 Seeking Alpha

KalVista Pharmaceuticals: Has Potential But With Caveats (NASDAQ:KALV)

Mar 12, 2026 Stock Titan

KalVista schedules April 15 webcast for Needham healthcare conference

Apr 8, 2026 Yahoo Finance

Does KalVista Pharmaceuticals (KALV) Have the Potential to Rally 117.98% as Wall Street Analysts Expect?

Jan 15, 2026 Stock Titan

Kids in KalVista trial treated attacks in 25 minutes with oral tablet

Mar 30, 2026 Yahoo Finance

KalVista Pharmaceuticals, Inc. (KALV) Reports Q3 Loss, Tops Revenue Estimates

Nov 10, 2025